Frontlight ResearchEarly access
Lung cancer trials in United States
900 trials · From ClinicalTrials.gov, checked 16 November 2026. Ask the study team whether a trial fits you.
- Phase 2WithdrawnIPH5201 and Durvalumab in Patients With Resectable Non-Small Cell Lung Cancer (MATISSE)
- Where
- Chicago, Houston, Lake Success, Madison, St. Petersburg, Tampa
- Age
- 18 years and over
- People
- 70 worldwide
- Run by
- Innate Pharma
See details and how to joinNCT05742607 - No phaseTaking peopleCHAMP Lung Cancer Screening Program
- Where
- Iowa City, Waterloo
- Age
- 50 years to 77 years
- People
- 300
- Run by
- Jill Kolesar
See details and how to joinNCT07572773 - Phase 2Taking peopleA Study Evaluating The Combination of Immunotherapy With Radiotherapy in Non-Small Cell Lung Cancer
- Where
- Chicago
- Age
- 18 years and over
- People
- 39
- Run by
- University of Chicago
See details and how to joinNCT07603856 - Phase 1Not yet taking people in United StatesA Study of CLSP 5282 in HLA-A*03:01 Positive Adult Patients With Solid Tumors (SENTINEL-101)
- Where
- Dallas, Durham, Nashville, Philadelphia
- Age
- 18 years and over
- People
- 140
- Run by
- Clasp Therapeutics, Inc.
See details and how to joinNCT07650357 - No phaseTaking peopleTempus Small Cell Lung Cancer Observational Study (Sculptor)
- Where
- Aurora, Baltimore, Chapel Hill, Cincinnati, Columbus, Englewood, Los Alamitos, Peoria, Tulsa, York
- Age
- 18 years and over
- People
- 200
- Run by
- Tempus AI
See details and how to joinNCT05257551 - Phase 2Taking peoplePembrolizumab for Advanced NSCLC and PS 2-3
- Where
- New York
- Age
- 18 years and over
- People
- 45
- Run by
- Icahn School of Medicine at Mount Sinai
See details and how to joinNCT05589818 - Phase 2Taking peopleDISCERN: Dual Versus Single ICB in PDL-1 Negative NSCLC
- Where
- Birmingham
- Age
- 18 years to 89 years
- People
- 24
- Run by
- University of Alabama at Birmingham
See details and how to joinNCT06364917 - No phaseTaking peopleData Collection for the Assessment of Acute and Late Normal Tissue in Patients Treated With Proton Therapy
- Where
- Houston
- Age
- 18 years and over
- People
- 5,000
- Run by
- M.D. Anderson Cancer Center
See details and how to joinNCT00991094 - Phase 2Taking peopleCanakinumab for the Prevention of Lung Cancer, the Can-Prevent-Lung Trial
- Where
- Houston
- Age
- 18 years and over
- People
- 50
- Run by
- M.D. Anderson Cancer Center
See details and how to joinNCT04789681 - Phase 1/2Taking peopleA Study to Evaluate the Safety and Efficacy of Mesothelin-Targeting Logic-gated CAR T, in Participants With Solid Tumors That Express MSLN and Have Lost HLA-A*02 Expression
- Where
- Columbus, Gilbert, Jacksonville, La Jolla, Los Angeles, Nashville, New York, Rochester, Seattle, Stanford, St Louis, Tampa
- Age
- 18 years and over
- People
- 474
- Run by
- A2 Biotherapeutics Inc.
See details and how to joinNCT06051695 - Phase 1Taking peopleFirst-in-Human Study of PLX-61639 in Locally Advanced or Metastatic Solid Tumors
- Where
- Boston, Cleveland, Duarte, Durham, Fairfax, New York, Orange, San Antonio, Scottsdale, St Louis
- Age
- 18 years and over
- People
- 155
- Run by
- Plexium, Inc.
See details and how to joinNCT07284186 - Phase 1/2Taking peoplePost-operative Urinary Retention (POUR) Following Thoracic Surgery
- Where
- Hackensack
- Age
- 50 years and over
- People
- 127
- Run by
- Hackensack Meridian Health
See details and how to joinNCT03609580 - Phase 2Taking peopleAvapritinib for the Treatment of CKIT or PDGFRA Mutation-Positive Locally Advanced or Metastatic Malignant Solid Tumors
- Where
- Houston
- Age
- 18 years and over
- People
- 50
- Run by
- M.D. Anderson Cancer Center
See details and how to joinNCT04771520 - Phase 1Taking peopleMEM-288 Oncolytic Virus Alone and in Combination With Standard of Care Therapy in Advanced Solid Tumors
- Where
- Durham, Tampa
- Age
- 18 years and over
- People
- 40
- Run by
- Memgen, Inc.
See details and how to joinNCT05076760 - Phase 1Taking peopleSafety and Tolerability of ²¹²Pb-DOTAM-GRPR1 in Adult Subjects With Recurrent or Metastatic GRPR-expressing Tumors
- Where
- Chicago, Glen Burnie, Iowa City, Lexington, Omaha, Pittsburgh
- Age
- 18 years and over
- People
- 48
- Run by
- Orano Med Theranostics, SAS
See details and how to joinNCT05283330 - Phase 1/2Taking peopleA Study to Investigate the Efficacy and Safety of an Infusion of IOV-4001 in Adult Participants With Unresectable or Metastatic Melanoma or Stage III or IV Non-small-cell Lung Cancer
- Where
- Cincinnati, Los Angeles, Louisville, Miami, Milwaukee, New York, Orlando, Pittsburgh, Tampa, Westwood
- Age
- 18 years to 70 years
- People
- 53
- Run by
- Iovance Biotherapeutics, Inc.
See details and how to joinNCT05361174 - Phase 1Taking peopleA Phase 1, First-in-human Study of OKN4395 and Pembrolizumab in Patients With Solid Tumors
- Where
- Beverly Hills, Houston, Santa Monica
- Age
- 18 years and over
- People
- 146 worldwide
- Run by
- Epkin
See details and how to joinNCT06789172 - Phase 1Enrolling by invitationA Phase 1/1b of RNDO-564 Single Agent or in Combination With Pembrolizumab in Bladder Cancer and Other Solid Tumors Associated With Nectin-4
- Where
- Grand Rapids, Houston, Huntersville, Myrtle Beach, Nashville, New Haven, New York, San Antonio, San Francisco, Seattle, West Valley City
- Age
- 18 years and over
- People
- 149
- Run by
- Rondo Therapeutics
See details and how to joinNCT07218003 - Phase 2Taking peopleA Study of Stereotactic Radiosurgery (SRS) for People With Lung Cancer That Has Spread to the Brain
- Where
- Basking Ridge, Commack, Harrison, Middletown, Montvale, New York, Rockville Centre
- Age
- 18 years and over
- People
- 62
- Run by
- Memorial Sloan Kettering Cancer Center
See details and how to joinNCT05419076 - Phase 1Taking peopleDose Determining Study of EXS74539 (REC-4539) in Participants With Select Solid Tumors
- Where
- Fort Worth, Los Angeles, West Valley City
- Age
- 18 years and over
- People
- 40
- Run by
- Exscientia AI Ltd., a wholly owned subsidiary of Recursion Pharmaceuticals, Inc.
See details and how to joinNCT07517198 - Phase 2Not yet taking people in United StatesThe Selective Personalized Radio-Immunotherapy for Locally Advanced Non-Small Cell Lung Cancer Trial 2
- Where
- The Bronx
- Age
- 18 years and over
- People
- 52
- Run by
- Montefiore Medical Center
See details and how to joinNCT07146230 - No phaseTaking peopleThe EASE Study: Randomized Trial of a Novel Approach to Addressing Fear of Progression in Advanced Cancer
- Where
- Aurora, Boulder
- Age
- 18 years and over
- People
- 250
- Run by
- University of Colorado, Boulder
See details and how to joinNCT07636200 - Early phase 1Not yet taking people in United StatesNebulized AER101 in Pre-op NSCLC
- Where
- Oklahoma City
- Age
- 18 years to 100 years
- People
- 5
- Run by
- University of Oklahoma
See details and how to joinNCT07631299 - Phase 1Not yet taking people in United StatesStudy of Pembrolizumab and Single Agent Chemotherapy as First Line Treatment for Patients With Locally Advanced or Metastatic Non-small Cell Lung Cancer With Eastern Cooperative Oncology Group (ECOG) Performance Status of 2
- Where
- Rochester
- Age
- 18 years and over
- People
- 60
- Run by
- University of Rochester
See details and how to joinNCT04297605 - Phase 1/2Taking peopleA Study to Evaluate the Safety, Tolerability, and Efficacy of MORAb-202 (Herein Referred to as Farletuzumab Ecteribulin), a Folate Receptor Alpha (FRα)-Targeting Antibody-drug Conjugate (ADC) in Participants With Selected Tumor Types
- Where
- Atlanta, Augusta, Baltimore, Camden, Charleston, Charlottesville, Chattanooga, Chicago, Cincinnati, Coral Gables, Detroit, Hilliard, Houston, Little Rock, Louisville, Nashville, New York, Palo Alto, Portland, Skokie, Tampa, Tucson
- Age
- 18 years and over
- People
- 182 worldwide
- Run by
- Eisai Inc.
See details and how to joinNCT04300556 · EU 2023-506868-14-00